natgillin/translations-raw huggingface dataset:
The active substance in Cubicin, daptomycin, is an antibiotic that belongs to the group ‘lipopeptides’.
Cubicini toimeaine daptomütsiin on lipopeptiidide rühma kuuluv antibiootikum.
The active substance in Daklinza, daclatasvir, blocks the action of a protein in the hepatitis C virus called ‘NS5A’, which is essential for the virus to multiply.
Daklinza toimeaine daklatasviir blokeerib C-hepatiidi viiruses oleva valgu NS5A, mida on vaja viiruse paljunemiseks.
The active substance in Darzalex, daratumumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to the protein CD38, which is found in high amounts on multiple myeloma cells.
Darzalexi toimeaine daratumumab on monoklonaalne antikeha (teatud valk), mis tunneb ära valgu CD38, mida leidub suures koguses hulgimüeloomi rakkude pinnal, ja seondub sellega.
The active substance in Deltyba, delamanid, is an antibiotic active against M. tuberculosis.
Deltyba toimeaine delamaniid on bakteri M. tuberculosis vastu aktiivne antibiootikum.
The active substance in Dexdor, dexmedetomidine, is a selective alpha-2 receptor agonist.
Dexdori toimeaine deksmedetomidiin on alfa-2-adrenoretseptorite selektiivne agonist.
The active substance in Dicural, difloxacin, belongs to a group of antibiotics called ‘fluoroquinolones’.
Dicurali toimeaine difloksatsiin kuulub fluorokinoloonideks nimetatavate antibiootikumide rühma.
The active substance in Docetaxel Winthrop, docetaxel, belongs to the group of anticancer medicines known as the taxanes.
Docetaxel Winthropi toimeaine dotsetakseel kuulub vähiravimite taksaanide rühma.
The active substance in Doribax, doripenem, is an antibiotic that belongs to the group ‘carbapenems’.
Doribaxi toimeaine doripeneem on karbapeneemide rühma kuuluv antibiootikum.
The active substance in Draxxin is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Draxxini toimeaine on Komisjoni määruse (EL) nr 37/2010 lisa tabelis 1 kirjeldatud lubatud aine:
The active substance in Draxxin, tulathromycin, is an antibiotic that belongs to the class ‘macrolides’.
Draxxini toimeaine tulatromütsiin on makroliidide rühma kuuluv antibiootikum.
The active substance in Dynastat, parecoxib, is a ‘prodrug’ of valdecoxib.
Dynastati toimeaine parekoksiib on valdekoksiibi eelravim.
The active substance in each Zerene hard capsule is zaleplon 10 mg.
Zerene üks kõvakapsel sisaldab toimeainena 10 mg zaleplooni.
The active substance in each Zerene hard capsule is zaleplon 5 mg.
Zerene üks kõvakapsel sisaldab toimeainena 5 mg zaleplooni.
The active substance in each Ziagen film-coated, scored tablet is 300 mg of abacavir (as sulfate).
Ziagen’i igas õhukese polümeerikattega poolitusjoonega tabletis on toimeaineteks 300 mg abakaviiri (sulfaadina).
The active substance in Ebilfumin, oseltamivir, acts specifically on the flu virus, blocking some of the enzymes on its surface known as neuramidases.
Ebilfumini toimeaine oseltamiviir toimib spetsiifiliselt gripiviiruse suhtes, blokeerides viirusepinna teatud ensüümid (neuraminidaasid).
The active substance in Ecalta, anidulafungin, is an antifungal medicine, which belongs to the group ‘echinocandins’.
Ecalta toimeaine anidulafungiin on ehhinokandiinide rühma kuuluv seenevastane aine.
The active substance in Ecansya, capecitabine, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells) that belongs to the group ‘anti-metabolites’.
Ecansya toimeaine kapetsitabiin on antimetaboliitide (raku normaalset ainevahetust pärssivate ainete) hulka kuuluv tsütotoksiline aine (ravim, mis hävitab poolduvaid rakke, näiteks vähirakke).
The active substance in Econor, valnemulin, is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Econor’i toimeaine valnemuliin kuulub lubatud toimeainete hulka, nagu on kirjeldatud komisjoni määruse (EL) nr 37/2010 lisas tabelis 1.
The active substance in Edarbi, azilsartan medoxomil, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Edarbi toimeaine asilsartaanmedoksomiil on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Edistride, dapagliflozin, works by blocking a protein in the kidneys called sodium-glucose co-transporter 2 (SGLT2).
Edistride toimeaine dapagliflosiin blokeerib neerudes valgu nimetusega naatriumi-glükoosi kotransporter 2 (SGLT2).
The active substance in Eklira Genuair, aclidinium bromide, is an anticholinergic bronchodilator.
Eklira Genuairi toimeaine aklidiiniumbromiid on antikolinergiline bronhodilataator.
The active substance in Elocta, efmoroctocog alfa, works in the body in the
Elocta toimeaine alfaefmoroktokog toimib
The active substance in Empliciti, elotuzumab, is a monoclonal antibody that activates the body’s immune cells to attack the multiple myeloma cancer cells.
Empliciti toimeaine elotuzumab on monoklonaalne antikeha, mis aktiveerib keha immuunrakke, et need ründaksid hulgimüeloomi vähirakke.
The active substance in Emtriva, emtricitabine, is a nucleoside reverse transcriptase inhibitor (NRTI).
Emtriva toimeaine emtritsitabiin on nukleosiid-pöördtranskriptaasi inhibiitor (NRTI).
The active substance in Enbrel is etanercept.
Toimeaine Enbrelis on etanertsept.
The active substance in Enbrel, etanercept, is a protein that has been designed to block the activity of a chemical messenger in the body called tumour necrosis factor (TNF).
Enbreli toimeaine etanertsept on valk, mis blokeerib organismis sisalduva virgatsaine – kasvaja nekroositeguri (TNF) – toime.
The active substance in EndolucinBeta, lutetium (177Lu) chloride, is a radioactive compound that mainly emits a type of radiation known as beta radiation, with small amounts of gamma radiation.
EndolucinBeta toimeaine luteetsium(177Lu)kloriid on radioaktiivne ühend, mis kiirgab peamiselt beetakiirgust (radioaktiivse kiirguse teatud tüüp) ja veidi gammakiirgust.
The active substance in Eperzan, albiglutide, is a ‘GLP-1 receptor agonist’.
Eperzani toimeaine albiglutiid on GLP-1 retseptori agonist.
The active substance in Epoetin Alfa Hexal, epoetin alfa, is a copy of a hormone called erythropoietin, and works in exactly the same way as the natural hormone to stimulate the production of red blood cells from the bone marrow.
Epoetin Alfa Hexali toimeaine alfaepoetiin on hormooni erütropoetiini koopia ja toimib täpselt samamoodi kui looduslik hormoon, stimuleerides luuüdis erütrotsüütide teket.
The active substance in EQUIOXX 8.2 mg/g oral paste for horses and EQUIOXX 20 mg/ml solution for injection for horses is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010 as follows:
Toimeaine EQUIOXX 8,2 mg suukaudne pasta hobustele ja EQUIOXX 20 mg /ml süstelahus hobustele on Komisjoni määruse (EL) nr 37/2010 lisa tabelis 1 kirjeldatud lubatud aine:
The active substance in EQUIOXX, firocoxib, is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the group of medicines called ‘cyclo-oxygenase-2 (COX-2) inhibitors’ (or Coxibs).
EQUIOXXis toimeainena sisalduv firokoksiib on mittesteroidne põletikuvastane ravim (NSAID), mis kuulub tsüklooksügenaas-2 (COX-2) inhibiitorite rühma.
The active substance in Erivedge, vismodegib, disrupts the so-called ‘Hedgehog signalling pathway’, which is normally involved in regulating the early stages of cell development in unborn babies and certain cell processes in adults.
Erivedge toimeaine vismodegiib häirib nn Hedgehogi signaali ülekanderada, mis osaleb tavaliselt loote rakkude arengu varastes staadiumides ja teatud rakuprotsessides täiskasvanutel.
The active substance in Esmya, ulipristal acetate, is a ‘selective progesterone receptor modulator’.
Esmya toimeaine ulipristaalatsetaat on selektiivne progesterooniretseptori modulaator.
The active substance in Exjade, deferasirox, is an ‘iron chelator’.
Exjade toimeaine deferasiroks on rauda kelaativ aine.
The active substance in Extavia, interferon beta-1b, belongs to a group of medicines known as ‘interferons’.
Extavia toimeaine beeta-1b-interferoon kuulub interferoonide rühma.
The active substance in Exviera, dasabuvir, works by blocking the action of an enzyme in the hepatitis C virus called ‘NS5B RNA-dependent polymerase’, which the virus needs to multiply.
Exviera toimeaine dasabuviir blokeerib C-hepatiidi viiruse ensüümi NS5B RNA-sõltuva RNA polümeraasi, mida on vaja viiruse paljunemiseks.
The active substance in Fabrazyme, agalsidase beta, is a copy of the human enzyme, produced by a method known as ‘recombinant DNA technology’: it is made by cells that have received a gene (DNA), which makes them able to produce the enzyme.
Fabrazyme toimeaine beeta-agalsidaas on inimensüümi koopia, mida valmistatakse rekombinant-DNA-tehnika abil: seda toodab rakk, millele on lisatud ensüümi teket võimaldav geen (DNA).
The active substance in Ferriprox, deferiprone, is an iron chelator.
Ferriproxi toimeaine deferiproon on rauda kelaativ aine.
The active substance in Firazyr, icatibant, blocks the receptors that bradykinin normally attaches itself to.
Firazyri toimeaine ikatibant blokeerib retseptorid, millele bradükiniin tavaliselt kinnitub.
The active substance in Flebogamma DIF, human normal immunoglobulin, is a highly purified protein extracted from human plasma (part of the blood).
Ravimi Flebogamma DIF toimeaine – inimese normaalne immunoglobuliin – on inimese vereplasmast (teatud verekomponendist) eraldatud ülipuhastatud valk.
The active substance in Forxiga, dapagliflozin, works by blocking a protein in the kidneys called sodium-glucose co-transporter 2 (SGLT2).
Ravimi Forxiga toimeaine dapagliflosiin blokeerib neerudes valgu nimetusega naatriumi-glükoosi kotransporter 2 (SGLT2).
The active substance in Gazyvaro, obinutuzumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to the protein CD20, which is found on the surface of B- lymphocytes.
Gazyvaro toimeaine obinutusumaab on monoklonaalne antikeha (teatud valk), mis tunneb ära B- lümfotsüütide pinnal oleva valgu CD20 ja seondub sellega.
The active substance in Gilenya, fingolimod, reduces the ability of T cells (a type of white blood cell involved in the immune system) to move from the lymph nodes towards the brain and spinal cord thus limiting the damage they cause in MS.
Gilenya toimeaine fingolimood vähendab T-rakkude (teatud valgelibled, mis kuuluvad immuunsüsteemi) võimet liikuda lümfisõlmedest pea- ja seljaaju suunas, vähendades sel teel kahjustusi, mida nad hulgiskleroosi korral põhjustavad.
The active substance in Gliolan, 5-aminolevulinic acid, is a ‘sensitiser used in photodynamic therapy’.
Gliolani toimeaine 5-aminolevuliinhape on fotodünaamilises ravis kasutatav sensitiseeriv (tundlikuks muutev) ühend.
The active substance in Glustin is pioglitazone.
Glustini toimeaine on pioglitasoon.
The active substance in Glybera, alipogene tiparvovec, is derived from a virus that has been modified so it can carry the lipoprotein lipase gene into the body’s cells.
Glybera toimeaine alipogeentiparvovek saadakse viirusest, mida on modifitseeritud viima organismi rakkudesse lipoproteiinlipaasi tekitavat geeni.
The active substance in GONAL-f, follitropin alfa, is a copy of the natural hormone FSH.
Ravimi GONAL–f toimeaine alfafollitropiin on loodusliku folliikuleid stimuleeriva hormooni (FSH) tehisvariant.
The active substance in Grastofil, filgrastim, is very similar to a human protein called granulocyte colony stimulating factor (G-CSF).
Grastofili toimeaine filgrastiim on väga sarnane inimvalguga, mida nimetatakse granülotsüütide kolooniat stimuleerivaks faktoriks (G-CSF).
The active substance in Helixate NexGen, human coagulation factor VIII, is a substance that helps the blood to clot.
Helicate NexGeni toimeaine inimese VIII hüübimistegur on vere hüübimist soodustav valk.
The active substance in Hepsera is adefovir dipivoxil.
Hepsera toimeaine on adefoviirdipivoksiil.
The active substance in Hepsera, adefovir dipivoxil, is a ‘prodrug’ that is converted into adefovir in the body.
Hepsera toimeaine adefoviirdipivoksiil on eelravim, mis muundub organismis adefoviiriks.
The active substance in Hirobriz Breezhaler, indacaterol, is a beta 2 adrenergic receptor agonist.
Hirobriz Breezhaleri toimeaine indakaterool on β2-adrenergilise retseptori agonist.
The active substance in Hizentra, human normal immunoglobulin, is a highly purified protein extracted from human plasma (part of the blood).
Hizentra toimeaine inimese normaalne immunoglobuliin on inimese vereplasmast (teatud verekomponent) eraldatud ülipuhastatud valk.
The active substance in Holoclar is the patient’s own limbal cells, which include cells from the surface of the cornea and limbal stem cells grown in a laboratory.
Holoclari toimeaine on patsiendi enda korneaallimbuse rakud, mis sisaldavad sarvkesta pinna rakke ja laboris kasvatatud korneaallimbuse tüvirakke.
The active substance in Humalog, insulin lispro, is produced by a method known as ‘recombinant DNA technology’: it is made by bacteria into which a gene (DNA) has been introduced, which makes them able to produce insulin lispro.
Humalogi toimeainet lisproinsuliini valmistatakse rekombinant-DNA-tehnika abil: seda toodavad bakterid, millele on lisatud lisproinsuliini teket võimaldav geen (DNA).
The active substance in Humira, adalimumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to a chemical messenger in the body called tumour necrosis factor (TNF).
Humira toimeaine adalimumaab on monoklonaalne antikeha (teatud valk), mis tunneb ära organismis leiduva virgatsaine kasvaja nekroositeguri (TNF) ja seondub sellega.
The active substance in Hycamtin, topotecan, is a cancer medicine that belongs to the group ‘topoisomerase inhibitors’.
Hycamtini toimeaine topotekaan on topoisomeraasi inhibiitorite rühma kuuluv vähiravim.
The active substance in Iclusig, ponatinib, belongs to a group of medicines called ‘tyrosine kinase inhibitors’.
Iclusigi toimeaine ponatiniib kuulub türosiinkinaasiinhibiitorite ravimirühma.
The active substance in IDELVION is albutrepenonacog alfa (recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP)).
IDELVION’i toimeaine on alfaalbutrepenonakog (rekombinantne liitvalk, mis ühendab IX faktorit albumiiniga (rIX-FP).
The active substance in Ifirmasta, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Ifirmasta toimeaine irbesartaan on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Ikervis, ciclosporin, acts on cells of the immune system (the body’s natural defences) that are involved in the processes that cause inflammation.
Ikervise toimeaine tsüklosporiin avaldab toimet immuunsüsteemi (organismi looduslik kaitsemehhanism) rakkudele, mis on seotud põletikku tekitavate protsessidega.
The active substance in Ilaris, canakinumab, is a monoclonal antibody, a type of protein that has been designed to recognise and attach to a specific structure (called an antigen) that is found on certain cells in the body.
Ilarise toimeaine kanakinumaab on monoklonaalne antikeha (teatud valk), mis tunneb ära teatud antigeeni (organismi teatud rakkudel leiduva spetsiifilise struktuuri) ja seondub sellega.
The active substance in Imbruvica, ibrutinib, works by blocking an enzyme called Bruton’s tyrosine kinase (Btk), which is mostly found in B lymphocytes.
Imbruvica toimeaine ibrutiniib blokeerib ensüümi Brutoni türosiinkinaasi (Btk), mida leidub enamasti B- lümfotsüütides.
The active substance in Imlygic, talimogene laherparepvec, is a type of gene therapy called ‘oncolytic virus’.
Imlygici toimeaine talimogeenlaherparepvek on geeniteraapiaravimite tüüp, mida nimetatakse onkolüütiliseks viiruseks.
The active substance in Imnovid, pomalidomide, is an immunomodulating agent.
Imnovidi toimeaine pomalidomiid on immunomoduleeriv aine.
The active substance in InductOs is dibotermin alfa (also called recombinant human Bone Morphogenetic Protein-2), 4 mg (4 mg pack) or 12 mg (12 mg pack).
InductOs’e toimeaine on alfadibotermiin (ehk rekombinantne inimese luu morfogeneetiline valk 2), 4 mg (4 mg pakend) või 12 mg (12 mg pakend).
The active substance in Inhixa is enoxaparin sodium.
Inhixa toimeaine on naatriumenoksapariin.
The active substance in Inhixa, enoxaparin, is one of a group of anticoagulant medicines called ‘low-molecular weight heparins’.
Inhixa toimeaine enoksapariin on antikoagulant, mis kuulub madalmolekulaarsete hepariinide rühma.
The active substance in Inlyta, axitinib, works by blocking some enzymes known as tyrosine kinases that are found in ‘vascular endothelial growth factor’ (VEGF) receptors on the surface of cancer cells.
Inlyta toimeaine aksitiniib blokeerib ensüüme türosiinkinaase, mis esinevad vaskulaarse endoteeli kasvuteguri (VEGF) retseptorites vähirakkude pinnal.
The active substance in Inovelon, rufinamide, is an anti-epileptic medicine.
Inoveloni toimeaine rufinamiid on epilepsiaravim.
The active substance in Insulin Human Winthrop, insulin human, is produced by a method known as ‘recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin.
Insulin Human Winthropi toimeainet iniminsuliini valmistatakse rekombinant-DNA-tehnika abil: seda toodab bakter, millele on lisatud insuliini teket võimaldav geen (DNA).
The active substance in Insuman, human insulin, is produced by a method known as ‘recombinant DNA technology’: it is made by bacteria into which a gene (DNA) has been introduced that makes the bacteria able to produce insulin.
Insumani toimeainet iniminsuliini valmistatakse rekombinant-DNA-tehnika abil: seda toodavad bakterid, millesse on viidud insuliini teket võimaldav geen (DNA).
The active substance in IntronA, interferon alfa-2b, belongs to the group ‘interferons’.
IntronA toimeaine alfa-2b-interferoon kuulub interferoonide rühma.
The active substance in Invanz, ertapenem, is an antibiotic that belongs to the group known as ‘carbapenems’.
Invanzi toimeaine ertapeneem on karbapeneemide rühma kuuluv antibiootikum.
The active substance in Invega, paliperidone, is an antipsychotic medicine.
Invega toimeaine paliperidoon on antipsühhootikum (psühhoosiravim).
The active substance in Ipreziv, azilsartan medoxomil, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Iprezivi toimeaine asilsartaanmedoksomiil on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Irbesartan BMS, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Irbesartan BMSi toimeaine irbesartaan on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Irbesartan Teva, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Irbesartan Teva toimeaine irbesartaan on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Irbesartan Zentiva, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Irbesartan Zentiva toimeaine irbesartaan on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Ivabradine Anpharm, ivabradine, works by blocking the ‘If currents’ in the sinus node, the natural ‘pacemaker’ that controls the heart’s contractions and regulates the heart rate.
Ivabradine Anpharmi toimeaine ivabradiin blokeerib siinussõlmes (südame kokkutõmbeid juhtiv ja löögisagedust reguleeriv südamepiirkond, loomulik rütmur) tekkiva nn If-voolu.
The active substance in Ivemend, fosaprepitant, is a ‘prodrug’ of aprepitant.
Ivemendi toimeaine fosaprepitant on aprepitandi eelravim.
The active substance in Jardiance, empagliflozin, works by blocking a protein in the kidneys called sodium-glucose co-transporter 2 (SGLT2).
Jardiance toimeaine empagliflosiin toimib, blokeerides neerudes naatriumglükoosi kotransporter 2 nimelise valgu (SGLT2).
The active substance in Jevtana, cabazitaxel, belongs to the group of cancer medicines known as ‘taxanes’.
Jevtana toimeaine kabasitakseel kuulub vähiravimite taksaanide rühma.
The active substance in Jinarc, tolvaptan, is a vasopressin-2-receptor antagonist: it works by blocking receptors in the kidneys to which the hormone vasopressin attaches.
Jinarci toimeaine tolvaptaan on vasopressiini V2-retseptori antagonist: see blokeerib neerudes retseptorid, millega seondub vasopressiini hormoon.
The active substance in Kalydeco, ivacaftor, increases the activity of the defective channels in patients with the mutations G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R or R117H.
Kalydeco toimeaine ivakaftoor suurendab mutatsioonidega (G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R või R117H) patsientidel kahjustatud kanalite aktiivsust.
The active substance in Karvea, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Karvea toimeaine irbesartaan on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Ketek, telithromycin, is an antibiotic belonging to the class ‘ketolides’.
Ketekis toimeainena sisalduv telitromütsiin on ketoliidide rühma kuuluv antibiootikum.
The active substance in Kineret, anakinra, is a copy of a natural human protein called ‘human interleukin 1 receptor antagonist’.
Kinereti toimeaine anakinra on inimese loodusliku valgu, inimese interleukiin-1 retseptori antagonisti analoog.
The active substance in Kineret, anakinra, is an immunosuppressive medicine (a medicine that reduces the activity of the immune system).
Kineretis toimeainena sisalduv anakinra on immuunsupressant (aine, mis pärsib immuunsüsteemi talitlust).
The active substance in Kinzalmono, telmisartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Kinzalmono toimeaine telmisartaan on angiotensiin II retseptori antagonist, mis blokeerib organismi hormooni angiotensiin II toime.
The active substance in Kiovig, human normal immunoglobulin, is a highly purified protein extracted from human plasma (part of the blood).
Kiovigi toimeaine – inimese normaalne immunoglobuliin – on inimese vereplasmast (teatud verekomponendist) eraldatud ülipuhastatud valk.
The active substance in Kogenate Bayer, human coagulation factor VIII, is a substance that helps the blood to clot.
Kogenate Bayeri toimeaine inimese VIII hüübimistegur on vere hüübimist soodustav valk.
The active substance in Lamivudine Teva Pharma B.V., lamivudine, is a nucleoside reverse transcriptase inhibitor (NRTI).
Lamivudine Teva Pharma B.V. toimeaine lamivudiin on nukleosiidne pöördtranskriptaasi inhibiitor (NRTI), mis blokeerib HIV-i tekitatava ensüümi pöördtranskriptaasi.
The active substance in Lantus, insulin glargine, is produced by a method known as ‘recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin glargine.
Lantuse toimeainet glargiininsuliini valmistatakse rekombinant-DNA-tehnika abil: glargiininsuliini toodab bakter, millele on lisatud glargiininsuliini teket võimaldav geen (DNA).
The active substance in Lartruvo, olaratumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to a protein called ‘platelet-derived growth factor receptor alpha’ (PDGFRα).
Lartruvo toimeaine olaratumaab on monoklonaalne antikeha (teatud valk), mis tunneb ära valgu, nimelt trombotsüütidest tuletatud kasvufaktori α-retseptori (PDGFRα), ja seondub sellega.